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Abstract
Background: Chlamydia, gonorrhoea and syphilis are readily treatable sexually transmitted infections (STIs) which
continue to occur at high rates in Australia, particularly among Aboriginal Australians. This study aimed to: explore
the extent of variation in delivery of recommended STI screening investigations and counselling within Aboriginal
primary health care (PHC) centres; identify the factors associated with variation in screening practices; and
determine if provision of STI testing and counselling increased with participation in continuous quality
improvement (CQI).
Methods: Preventive health audits (n = 16,086) were conducted at 137 Aboriginal PHC centres participating in the
Audit and Best Practice for Chronic Disease Program, 2005–2014. STI testing and counselling data were analysed to
determine levels of variation in chlamydia, syphilis and gonorrhoea testing and sexual health discussions. Multilevel
logistic regression was used to determine factors associated with higher levels of STI-related service delivery and to
quantify variation attributable to health centre and client characteristics.
Results: Significant variation in STI testing and counselling exists among Aboriginal PHC centres with health centre
factors accounting for 43% of variation between health centres and jurisdictions. Health centre factors
independently associated with higher levels of STI testing and counselling included provision of an adult health
check (odds ratio (OR) 3.40; 95% Confidence Interval (CI) 3.07-3.77) and having conducted 1–2 cycles of CQI (OR 1.
34; 95% CI 1.16-1.55). Client factors associated with higher levels of STI testing and counselling were being female
(OR 1.45; 95% CI 1.33-1.57), Aboriginal (OR 1.46; 95% CI 1.15-1.84) and aged 20–24 years (OR 3.84; 95% CI 3.07-4.80).
For females, having a Pap smear test was also associated with STI testing and counselling (OR 4.39; 95% CI 3.84-5.
03). There was no clear association between CQI experience beyond two CQI cycles and higher levels of
documented delivery of STI testing and counselling services.
Conclusions: A number of Aboriginal PHC centres are achieving high rates of STI testing and counselling, while a
significant number are not. STI-related service delivery could be substantially improved through focussed efforts to
support health centres with relatively lower documented evidence of adherence to best practice guidelines.
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Background
Preventable and curable sexually transmitted infections
(STIs) including chlamydia, gonorrhoea and syphilis con-
tinue to be a major cause for concern in Australia, particu-
larly among Aboriginal and Torres Strait Islander (hereafter
respectfully referred to as Aboriginal) Australians.
There are large disparities in STI notification rates
between Aboriginal and non-Aboriginal Australians
with gonorrhoea, syphilis, and chlamydia, 10 times, 6
times and 3 times higher among Aboriginal compared
to non-Aboriginal Australians [1]. Among Aboriginal
Australians, young people aged 15–29 years are the
most affected group, accounting for 82% of chlamydia
notifications and 72% of gonorrhoea notifications [2].
Furthermore, Aboriginal Australians living in remote
and very remote areas are burdened by significantly
higher rates of STIs compared to those in urban and
regional areas. For example, in 2015, the chlamydia
notification rates among the Aboriginal population
compared to the non-Aboriginal population was 2
times higher in major cities, 2 times higher in inner
regional centres, 5 times higher in outer regional
areas, 8 times higher in remote areas and 6 times
higher in very remote areas. Disparities are even more
marked for gonorrhoea, with notification rates 2 times
higher in Aboriginal people compared to non-
Aboriginal Australians in major cities and inner re-
gional areas, 20 times higher in outer regional areas,
72 times higher in remote areas and 32 times higher
in very remote areas [2]. For syphilis, rates in remote
and very remote areas are 132 times and 70 times
higher among Aboriginal Australians compared to
non-Aboriginal Australians, respectively.
A number of guidelines provide recommendations on
frequency of STI testing among Aboriginal clients attend-
ing primary health care (PHC) centres in Australia [3, 4],
with National Aboriginal Community Controlled Health
Organisation (NACCHO) preventive health guidelines
recommending annual testing for chlamydia (15–29
year age group) and gonorrhoea (15–39 year age
group) (see Table 1). Despite the high rates of STIs
and efforts related to policy and practice, low rates of
STI testing [5] and retesting [6] among eligible males
and females in Australia continue to be documented.
Over the past decade there have been a number of
interventions to improve the quality of sexual health
care for Aboriginal clients attending general practice
in Australia including the Sexual Health Quality Improve-
ment Project (SHIMMER) project in New South Wales
(NSW) [7]; the STI in Remote communities: Improved
and enhanced primary health care (STRIVE) project in
the Northern Territory (NT), Queensland (QLD) and
Western Australia (WA) [8]; and the Audit and Best
Practice for Chronic Disease (ABCD) Program in the NT,
QLD, NSW, WA and South Australia (SA) [9, 10]. The
ABCD Program, in conjunction with One21seventy, a
service support agency, supports systematic continuous
quality improvement (CQI) in a wide range of commu-
nity- and government-controlled PHC centres, providing
opportunities for health centres to identify gaps and
address barriers to evidence-based practice.
Under the ABCD Program, health centres undertake
preventive health clinical audits to assess documented
provision of preventive health care for their clients,
including delivery of sexual health care services, to de-
termine levels of adherence to best practice. The audit
processes allow health centres to benchmark themselves
against other health centres, make judgements about
their delivery of care, and determine priorities for im-
provement. Over 270 health centres have been involved
in the ABCD/One21seventy program and 175 health
centres voluntarily provided their audit data to the
ABCD National Research Partnership (NRP) for further
data analysis [11].
The aim of this study was to quantify the extent of
variation in specific processes of care related to sexual
health among Aboriginal primary health care centres
using data obtained through the ABCD NRP. Specific-
ally, the study aimed to: determine the factors at health
centre and client level associated with variation in STI
testing and counselling; quantify the variation attribut-
able to health centre and client characteristics; and
Table 1 Recommended schedule for testing for chlamydia, gonorrhoea, syphilis and adult health checks in Australia
Guideline Test/STI Target age group Frequency
RACGP [4] Chlamydia Sexually active 15–29 years Annuallya
NACCHO/RACGP [3] Chlamydia - Sexually active 15–29 years Annually
- 30 years and above who are deemed to be at risk
NACCHO/RACGP [3] Gonorrhoea Sexually active people aged 15–39 years Annually
NACCHO/RACGP [3] Sexual health counseling All sexually active persons Opportunistically
CARPA [43] Adult health checks including screening for
chlamydia, gonorrhoea and syphillis
Aboriginal people aged 15–54 years 2 yearly
aRepeat testing at 3–12 months if found to be positive and treated for chlamydia; CARPA Central Australian Rural Practitioners Association; NACCHO National
Aboriginal Community Controlled Health Organisation; RACGP Royal Australian College of General Practitioners
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determine if provision of sexual health prevention/
screening services increased with participation in CQI.
Methods
Setting
One hundred and thirty seven participating primary
health centres in the ABCD NRP provided preventive
health audit data between 2005 and 2014. These centres
predominantly serve Aboriginal clients and include urban,
regional and remote government- and community-
controlled primary health care centres from 5 jurisdictions
in Australia: NSW, NT, WA, SA and QLD. Based on a
comprehensive care model and providing clinical services,
health promotion and community care, Aboriginal PHC
centres range in size and staffing and employ a range of
health workers including general practitioners, nurses,
allied health practitioners, mental health professionals,
and Aboriginal health workers [12]. Some remote centres
are staffed by a single nurse and Aboriginal Health
Worker (AHW), with minimal administrative support
and a visiting doctor while larger centres have several
nurses, AHWs and doctors, and on-site allied health
and specialised services.
Data sources/collection
Details of the audit process have been documented else-
where [13, 14]. In summary, clinical audits were con-
ducted on a random sample of eligible client medical
records at each health centre. For health centres with 30
or more eligible clients, the One21seventy training man-
ual [15] provides guidance to auditors on how to draw
random samples of medical records from eligible clients
based on a precision of 90% or 95% confidence of that
sample representing the population from which it was
drawn. If the health centre’s population sample was less
than 30 clients, the One21seventy training manual
recommended that all records were audited [15]. Audits
are conducted by health centre staff trained in the use of
audit tools, supported by local or regional CQI facilita-
tors. The preventive services audit tool, introduced in
2005, assesses the delivery of preventive health care
against evidence-based guidelines for 15–54 year old
clients without a history of chronic disease. The tool
audits documentation of risk factors and brief interven-
tions, scheduled services including sexual, oral, ear and
eye health checks, and emotional wellbeing assessments.
For inclusion in the preventive audit the client has to be
1) aged between 15 and 54 years; 2) have been a resident
in the community for at least six of the last twelve
months; 3) not have a diagnosis of chronic disease (dia-
betes, hypertension, coronary heart disease, chronic
heart failure, rheumatic heart disease or chronic kidney
disease); and 4) not be pregnant or less than 6 weeks
postpartum at time of the audit. For the preventive tool,
a service is considered as delivered if there is a clear
record of delivery at least once in the last 24 months.
Samples were stratified by age and gender. Analysis was
confined to data related to sexual health care processes
included within the clinical audit tool: documentation of
a sexual and reproductive health (SRH) discussion, nu-
cleic acid amplification test (NAAT) test for gonorrhoea
and chlamydia and syphilis serology test. Other client
information collected included age, gender, Aboriginal
status, whether or not the client had attended in the pre-
vious 6 months, whether they had received an adult
health check (AHC), reason for last attendance, which
cadre of health provider they had seen first (doctor,
nurse or AHW) and, for females, whether they had received
a Pap smear. Health centre characteristics data collected
included the location (urban, regional or remote), govern-
ance structure (government- or community-controlled),
accreditation status, health service population, and CQI
experience (number of clinical audit cycles conducted).
Statistical analysis
STATA version 14 software (StataCorp, College Station,
TX, USA) was used for statistical analysis. To assess
delivery of STI testing and counselling, a sexual health
delivery composite outcome measure was created which
included sexual and reproductive health (SRH) discus-
sion, NAAT test for gonorrhoea and chlamydia, and
syphilis serology test by calculating the proportion of
screening/counselling services received out of the total
number of services the client should have received based
on the audit protocol. The composite measure is
expressed as a percentage; for instance if a client re-
ceived all three services, this is expressed as “100% of
recommended services were delivered to the client”. To
determine variation in STI testing and counselling at the
health centre level, the mean number of recommended
tests/counselling delivered by each health centre to their
eligible clients within an audit cycle or year was calcu-
lated. For logistic regression analysis, each composite
measure score was converted to a binary outcome vari-
able that categorised ‘higher’ performance as attaining
100% of service delivery, and anything less as ‘lower’
performance.
For unadjusted analysis, crude odds ratios were calcu-
lated to determine the association between the predictor
variables (health centre and client factors) and the com-
posite measure; the odds in this instance are ‘the odds of
a patient receiving 100% of service delivery’ in compari-
son to the reference group. For multilevel logistic regres-
sion analysis a step-wise model was used starting with
Model A to test the influence of health centres and
jurisdictions on sexual health service delivery over audit
years; health centre characteristics were added in Model
B and in Model C, patient characteristics were included.
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This model allowed for the hierarchical structure of the
data, that is, patients nested within health centres,
nested within jurisdictions [14]. Only significant vari-
ables from the unadjusted regressions were included in
models B and C. A sub-analysis was also conducted to
determine factors associated with STI testing and coun-
selling among female clients.
A median odds ratio (MOR) was used to quantify the
variance in odds ratio scale, i.e. the increase in median
probability of better delivery if a client moved from one
randomly selected health centre/jurisdiction to another
[16]. The MOR represents the median increased odds of
a patient receiving ‘100% of service delivery’ if they were
to change health centre/state. If the MOR = 1, there is
no difference between groups. In addition, the propor-
tional change in variance (PCV) was used to estimate
the reduction in variance due to the step-wise introduc-
tion of variables into the model [17]. The significance
level was set at p < 0.005 to account for the multiple
associations tested between the outcome indicators and
patient and health centre characteristics (Bonferroni
correction [18]).
Results
Of the 137 centres that audited for preventive services
between 2005 and 2014, 45% were in the NT and 36% in
QLD (Table 2). Seventy nine percent of the centres were
located in remote areas; most (73%) were government-
administered clinics; 49% had a service population equal
or less than 500 people and 44% of health centres had
completed 3 or more preventive audit cycles. Thirty one
percent of the centres were accredited for the whole
time period.
There were 16,086 clinical records audited between
2005 and 2014, 41% in QLD and 39% in NT (Table 3);
51% of clients were aged 15–29 years (mean 31 years);
50% were males; 88% were Aboriginal. Sixty-eight per-
cent of clients had attended the clinics in the last
6 months, 49% for acute care and only 8% specifically
for sexual health; 50% were first seen by a nurse, 20% by
an AHW. Around one-quarter (26%) of clients had
received an AHC in the previous 24 months, 8% in
NSW, 18% in QLD, 36% in the NT and 55% in SA.
Of those who attended the centres in the 24 months
prior to auditing (n = 15,212), 46% had a documented his-
tory of a sexual and reproductive health discussion, with
the highest in NT (49%) (Table 4); 49% had a NAAT test
for gonorrhoea and chlamydia documented (61% in NT
and 49% in QLD); and 41% had a syphilis test, highest in
NT (51%) and QLD (44%). For clients aged 15–29 years
(data not shown), 52% had a documented history of a
sexual health discussion, highest in SA (55%) and 56% had
a documentation of a NAAT test for gonorrhoea and chla-
mydia (65% in NT and 59% in QLD). Forty seven percent
of 15–29 years olds had a syphilis test with the highest in
NT (55%) and QLD (53%).
There was wide variation in delivery of STI tests and
counselling between health centres (Fig. 1), ranging from
Table 2 Health centre characteristics by jurisdiction (Number and % of total)
Far West NSW Northern Territory Queensland South Australia Western Australia Total
Health centre level Number of health
centres audited
6 62 49 8 12 137
Location Urban 0 (0) 1 (2) 3 (6) 4 (50) 3 (25) 11 (8)
Regional 3 (50) 3 (5) 6 (12) 2 (25) 4 (33) 18 (13)
Remote 3 (50) 58 (94) 40 (82) 2 (25) 5 (42) 108 (79)
Governance Community controlled 6 (100) 19 (31) 1 (2) 4 (50) 7 (58) 37 (27)
Government 0 (0) 43 (69) 48 (98) 4 (50) 5 (42) 100 (73)
Length of
Accreditationa
Never accredited 4 (67) 34 (55) 5 (10) 2 (25) 0 (0) 45 (33)
Accredited for some of
the time
1 (17) 6 (10) 21 (43) 2 (25) 0 (0) 30 (22)
Accredited for all of the time 1 (17) 13 (21) 22 (45) 4 (50) 3 (25) 43 (31)
Missing 0 (0) 9 (15) 1 (2) 0 (0) 9 (75) 19 (14)
Service population = < 500 2 (33) 35 (56) 26 (53) 3 (38) 1 (8) 67 (49)
501-999 1 (17) 11 (18) 9 (18) 3 (38) 0 (0) 24 (18)
= > 1000 3 (50) 16 (26) 14 (29) 2 (25) 11 (92) 46 (34)
CQI experience Baseline audit only 0 (0) 15 (24) 7 (14) 4 (50) 2 (17) 28 (20)
Completed 1–2 cycles 0 (0) 19 (31) 19 (39) 4 (50) 7 (58) 49 (36)
Completed = > 3 cycles 6 (100) 28 (45) 23 (47) 0 (0) 3 (25) 60 (44)
aaccreditation with Australian General Practice Accreditation Limited (AGPAL), Quality Improvement Council (QIC) or other, CQI continuous quality improvement,
NSW New South Wales
Nattabi et al. BMC Infectious Diseases  (2017) 17:148 Page 4 of 13










Client level Number of client
records audited
1293 6328 6639 675 1151 16086
Age group (years) 15-19 222 (17) 1,070 (17) 1,330 (20) 171 (25) 186 (16) 2,979 (19)
20-24 204 (16) 1,305 (21) 1,143 (17) 89 (13) 202 (18) 2,943 (18)
25-29 156 (12) 1,020 (16) 885 (13) 87 (13) 143 (12) 2,291 (14)
30-34 127 (10) 784 (12) 756 (11) 81 (12) 126 (11) 1,874 (12)
35-39 145 (11) 611 (10) 720 (11) 75 (11) 137 (12) 1,688 (10)
40-44 193 (15) 694 (11) 773 (12) 59 (9) 159 (14) 1,878 (12)
45-49 137 (11) 538 (9) 597 (9) 64 (9) 127 (11) 1,463 (9)
50-54 109 (8) 306 (5) 435 (7) 49 (7) 71 (6) 970 (6)
Gender Male 654 (51) 3163 (50) 3347 (50) 362 (54) 565 (49) 8091 (50)
Female 639 (49) 3165 (50) 3292 (50) 313 (46) 586 (51) 7995 (50)
Aboriginal status Aboriginal 983 (76) 6099 (96) 5451 (82) 657 (97) 1031 (90) 14221 (88)
Non-Aboriginal 245 (19) 173 (3) 581 (9) 18 (3) 84 (7) 1101 (7)
Not recorded 65 (5) 56 (1) 607 (9) 0 (0) 36 (3) 764 (5)
Time since last attendance <6 months 732 (57) 4832 (76) 4419 (67) 383 (57) 594 (52) 10960 (68)
>6 months 561 (43) 1496 (24) 2220 (33) 292 (43) 557 (48) 5126 (32)
Reason for last attendance Well person’s check 62 (5) 758 (12) 670 (10) 211 (31) 76 (7) 1777 (11)
Acute care 549 (42) 3237 (51) 3392 (51) 160 (24) 550 (48) 7888 (49)
Sexual health 69 (5) 433 (7) 661 (10) 41 (6) 42 (4) 1246 (8)
Othera 536 (41) 1773 (28) 1611 (24) 232 (34) 459 (40) 4611 (29)
Did not attend in last 2
years/Not recorded
77 (6) 127 (2) 305 (5) 31 (5) 24 (2) 564 (4)
First seen health provider AHW 119 (9) 1046 (17) 1302 (20) 318 (47) 403 (35) 3188 (20)
Nurse 453 (35) 3834 (61) 3244 (49) 240 (36) 207 (18) 7978 (50)
Doctors 419 (32) 875 (14) 1269 (19) 43 (6) 421 (37) 3027 (19)
Othersb 117 (9) 261 (4) 156 (2) 42 (6) 82 (7) 658 (4)
Did not attend in last 2
years/Not recorded
185 (14) 312 (5) 668 (10) 32 (5) 38 (3) 1235 (8)
Adult health check/
alternative health check
No 565 (44) 2670 (42) 5044 (76) 273 (40) 412 (36) 8964 (56)
Yes 98 (8) 2301 (36) 1164 (18) 371 (55) 185 (16) 4119 (26)
Did not attend in last 2 years/
Not recorded
630 (49) 1357 (21) 431 (6) 31 (5) 554 (48) 3003 (19)
amental health, immunisation, antenatal, other; bSpecialist, allied health, other; AHW Aboriginal Health Worker, NSW New South Wales
Table 4 Percentage of clients (15–54 years) who received STI tests and counselling in previous 24 months
Far West NSW Northern Territory Queensland South Australia Western Australia Total
SRH discussion 26 49 46 45.5 31 46
NAAT for gonorrhoea and chlamydia test 17 61 49 27 23 49
Syphilis serology 7 51 44 13 14 41
Received all STI tests and SRH discussiona 6 41 33 8 12 31
apre-2010 sexual health discussion data was not collected; NAAT nucleic acid amplification test, NSW New South Wales, SRH Sexual and Reproductive Health
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0% to 100% of services provided in some years/cycles.
Between 2005/6 and 2014, there was an increase in the
median percentage of STI tests and counselling services
provided to clients (27% to 54%) and a reduction in the
interquartile range (47.3% to 29.7%) suggesting a general
trend in improvement in service delivery (Fig. 1a). For
the 90 centres that conducted 3 or more CQI cycles,
there were marginal increases in the median percentage
of STI tests and counselling services over the 3 CQI
cycles (46.1% to 53.8%) (Fig. 1b).
Unadjusted regression analysis of the sexual health
delivery composite revealed a significant association with
duration of participation in the ABCD CQI program,
provision of an AHC, location, gender, age and Aborigi-
nal status (Table 5). Health centres that provided AHCs
were more likely to provide STI testing and counselling
than those that had not provided AHCs; regional centres
were less likely to provide these services compared to
urban and remote health centres. Health centres that
had conducted 1–2 CQI cycles were more likely to pro-
vide STI testing and counselling than those that had
conducted a baseline audit, however, this was not sus-
tained in subsequent cycles. Those clients who were
female, aged 15–39 years, and Aboriginal were more
likely to receive STI testing/counselling than those who
were male, aged older than 39 years and non-Aboriginal,
respectively.
In the adjusted analysis of the sexual health delivery
composite, health centre factors that remained associ-
ated with higher levels of STI testing and counselling
were provision of an AHC (adjusted odds ratio (AOR)
3.40; 95% confidence interval (CI) 3.07-3.77) and having
conducted 1–2 cycles of CQI (AOR 1.34; 95% CI 1.16-
1.55) (Table 5: Model C). Client level factors significantly
associated with higher levels of sexual health care
delivery were being female (AOR 1.45; 95% CI 1.33-
1.57), and Aboriginal compared to non-Aboriginal (AOR
1.46; 95% CI 1.15-1.84) with those aged 20–24 years and
25–29 years having the highest likelihood of receiving
STI testing and counselling (AOR 3.84; 95% CI 3.07-
4.80; AOR 3.01; 95% CI 2.39-3.79 respectively) compared
to those aged 15–19 years and over 29 years. In the sub-
analysis for females, Pap smear was significantly associ-
ated with STI testing and counselling in unadjusted and
adjusted analysis with those who had had a Pap smear
significantly more likely to receive STI testing and coun-
selling (AOR 4.39; 95% CI 3.84-5.03; p < .0001) (Table 6).
The variation in delivery of the sexual health compos-
ite was reduced between jurisdictions and health centres
after accounting for health centre factors as shown by
the reduction in the MORSTATE-HC from 3.70 (Table 5;
Model A) to 2.69 (Table 5, Model B). The PCV for STI
testing and counselling in Model B (Table 5) showed
that the addition of health centre factors explained 43%
of variation across jurisdictions and health centres. The
addition of client factors in the model had little impact
on explaining the remaining variation.
Discussion
This study is the first of its kind in Australia, providing
STI testing and counselling data from the largest and
longest running CQI program within Aboriginal primary
care, across five states and territories, involving govern-
ment- and community-controlled, urban, regional and
remote health centres. The study quantified the extent
of variation in STI testing and counselling within Abori-
ginal primary health care centres and demonstrated that
a significant proportion of variation was explained by
health centre factors. It has shown that a number of
jurisdictions and Aboriginal PHC centres are achieving
Fig. 1 Sexual health related service delivery over time: Mean percentage of STI testing and counsellinga delivered per health centre over audit
year (a) and cycle (b) (n = number of health centres; number of client records).aComposite indicator includes NAAT for gonorrhoea and
chlamydia, syphilis screen and reproductive health discussion
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Table 5 Unadjusted and adjusted multilevel logistic regression analysis of health centre and client level factors on composite
indicator of recommended STI testing and counselling services (n = 137 health centres; 15,212 patient records)
Outcome is 100% service delivery Unadjusted Model A Model B Model C
Predictors Fixed effects OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Audit Year 2007 1.00 (reference) 1.00 (reference) 1.00 (reference)
2008 0.65 (0.46-0.91) 0.79 (0.55-1.12) 0.82 (0.57-1.19)
2009 0.65 (0.47-0.92) 0.73 (0.51-1.04) 0.74 (0.51-1.06)
2010 0.44 (0.31-0.63)b 0.50 (0.34-0.73)b 0.49 (0.33-0.73)b
2011 0.34 (0.24-0.47)b 0.43 (0.30-0.63)b 0.43 (0.29-0.63)b
2012 0.51 (0.36-0.72)b 0.56 (0.38-0.83)a 0.57 (0.38-0.85)
2013 0.61 (0.43-0.86) 0.71 (0.48-1.05) 0.71 (0.48-1.06)
2014 0.57 (0.40-0.82)a 0.66 (0.43-1.00) 0.62 (0.40-0.94)
Health Centre Characteristics
Location Urban 1.00 (reference) 1.00 (reference) 1.00 (reference)
Regional 0.25 (0.12-0.56)a 0.41 (0.19-0.86) 0.38 (0.18-0.80)
Remote 1.71 (0.88-3.34) 2.09 (1.12-3.90) 1.98 (1.05-3.74)
Governance Community-controlled 1.00 (reference)
Government operated 0.78 (0.49-1.23)
Service population ≥1000 1.00 (reference)
>500- < 1000 1.30 (0.78-2.17)
≤500 1.31 (0.88-1.96)
Length of accreditationa Never accredited 1.00 (reference)
Accredited for some of the time 1.45 (0.94-2.24)
Accredited for all of the time 0.73 (0.49-1.06)
Duration of participation in
ABCD CQI project
Baseline 1.00 (reference) 1.00 (reference) 1.00 (reference)
1-2 cycles 1.49 (1.35-1.64)b 1.30 (1.12-1.50)b 1.34 (1.16-1.55)b
≥3 cycles 1.11 (0.98-1.24) 0.97 (0.78-1.20) 1.01 (0.81-1.26)
Provided adult health checkb No 1.00 (reference) 1.00 (reference) 1.00 (reference)
Yes 3.17 (2.88-3.50)b 3.25 (2.94-3.59)b 3.40 (3.07-3.77)b
Patient Characteristics
Sex Male 1.00 (reference) 1.00 (reference)
Female 1.41 (1.30-1.52)b 1.45 (1.33-1.57)b
Age (years) 15-19 1.82 (1.48-2.22)b 2.10 (1.67-2.63)b
20-24 3.21 (2.63-3.92)b 3.84 (3.07-4.80)b
25-29 2.82 (2.30-3.47)b 3.01 (2.39-3.79)b
30-24 2.15 (1.74-2.65)b 2.35 (1.85-2.97)b
35-39 1.72 (1.38-2.13)b 1.77 (1.39-2.26)b
40-44 1.35 (1.08-1.67) 1.36 (1.07-1.73)
45-49 1.17 (0.93-1.47) 1.27 (0.99-1.63)
50-54 1.00 (reference) 1.00 (reference)
Aboriginal Status Non-Aboriginal 1.00 (reference) 1.00 (reference)
Aboriginal 2.10 (1.70-2.61)b 1.46 (1.15-1.84)a
Not recorded 1.55 (1.13-2.12) 1.09 (0.77-1.55)
Random effects (intercepts)
State (variance (SE)) 1.05 (0.71) 0.54 (0.39) 0.55 (0.395)
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high rates of STI testing but that there are substantial
opportunities for improvement in the STI testing and
counselling in many Aboriginal PHC centres.
Wide variation in service delivery in Aboriginal PHC
centres has been documented in previous studies of CQI
in diabetes care [14], preventive care [19] and cardiovas-
cular care [20]. In a study of CQI in diabetes care, vari-
ation reduced over audit cycles with lower performing
centres showing improvements in adherence to best
practice, and with a significant association between
duration of CQI participation and the improvement in
diabetes care processes [14]. In contrast, though there
were marginal improvements in the median percentage
of STI tests and counselling services delivered over CQI
cycles, the current analysis shows no clear association
between CQI experience and higher levels of docu-
mented delivery of sexual health care, with continuing
low levels of documented STI testing and counselling in
some health centres despite participation in several
cycles of CQI. The preventive tool audit process was not
focused on sexual health delivery but on preventive care
in general, with health centres setting goals and imple-
mentation strategies based on audit findings, context-
specific priorities and available resources. Following on
from the findings of Matthews et al. [14], analysis of the
diabetes data that shows there was an association of im-
proved level of care with longer duration of participation
in CQI, the findings from this analysis of the sexual
health data suggest that without specific focus on sexual
health, a more general preventive health CQI process
may not necessarily result in improved sexual health
care in the medium to long term, even though there is
an association between duration of CQI in preventive
health and STI counselling and testing over the initial
1–2 years. Further understanding about whether it was a
lack of prioritisation of sexual health or other factors
that impacted on delivery of sexual health care will have
implications for the development of tailored strategies to
improve the delivery of sexual health care in this context.
As pointed out in Larkins et al. 2016 [21], trends in quality
of care varied widely between health services across differ-
ent audit tools, “point[ing] to the need for a deeper or
more nuanced understanding of factors that moderate the
effect of CQI on health service performance”.
This study also found a positive association between
Pap smear and STI testing in female clients. Cervical
screening among the Aboriginal female population is
important given that the incidence of and mortality from
cervical cancer is higher among Aboriginal women com-
pared to non-Aboriginal women [22, 23] but also be-
cause a Pap smear provides an opportunity for STI
testing [24]. Opportunities to maintain and intensify
cervical screening rates among Aboriginal women is key
to reducing cervical cancer incidence and mortality rates
but also for maintaining STI testing rates among Abori-
ginal women [24]. Changes will occur in Australia’s
cervical cancer screening program from 2017 which will
incorporate a primary Human Papillomavirus (HPV) test
every 5 years and reduce the requirement for 2-yearly
Pap tests as occurs currently [25] and could impact on
STI testing rates among female general practice clients.
Data collection as occurs through ABCD NRP/One21se-
venty provide important infrastructure by which to
measure the impact of such policy changes on a key
target group.
Our findings that females and clients aged 20–24 years
receive higher levels of STI testing in comparison to
males and other age groups, respectively, has been docu-
mented elsewhere [26]. Kong et al. [5] found that the
rate of STI testing at general practice was higher in
Table 5 Unadjusted and adjusted multilevel logistic regression analysis of health centre and client level factors on composite
indicator of recommended STI testing and counselling services (n = 137 health centres; 15,212 patient records) (Continued)
MORSTATE 2.66 2.02 2.03
PCV (% explained variance) 48% 47%
Health Centre (variance (SE)) 0.84 (0.14) 0.54 (0.09) 0.55 (0.095)
MORHC 2.39 2.01 2.03
PCV (% explained variance) 36% 34%
State & Health Centre (variance) 1.89 1.08 1.11
MORSTATE-HC 3.70 2.69 2.73
PCV (% explained variance) 43% 41%
Patient (variance (SE)) 0.28 (0.14) 0.12 (0.055) 0.03 (0.015)
PCV (% explained variance) 59% 89%
CQI continuous quality improvement, MOR Median Odds Ratio: odds of receiving above median service delivery if client was to change health centre or
jurisdiction, OR Odds Ratio, PCV proportional change in variance: per cent variation explained in odds for better healthcare delivery by introduction of health
centre or client level factors, SRH Sexual and Reproductive Health
Due to multiple testing, the significance level is set at p < 0.005 (Bonferroni correction); ap < 0.005; bp < 0.0001
a(n = 13,989 with accreditation status recorded); b(n = 13,235 with AHC recorded, introduced to audit tool in 2007)
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Table 6 Adjusted multilevel logistic regression analysis of health centre and client level factors on composite indicator of
recommended STI testing and counselling services for female clients (n = 137 health centres; 7,670 female patient records)
Outcome is 100% service delivery Model A Model B Model C
Predictors Fixed effects OR 95% CI OR 95% CI OR 95% CI
Audit Year 2007 1.00 (reference) 1.00 (reference) 1.00 (reference)
2008 0.73 (0.45-1.18) 1.04 (0.63-1.74) 1.13 (0.66-1.91)
2009 0.70 (0.43-1.14) 0.87 (0.52-1.45) 0.88 (0.52-1.50)
2010 0.58 (0.35-0.95) 0.75 (0.44-1.29) 0.75 (0.43-1.30)
2011 0.44 (0.27-0.71)a 0.61 (0.36-1.03) 0.61 (0.36-1.05)
2012 0.61 (0.38-1.00) 0.69 (0.41-1.17) 0.70 (0.41-1.21)
2013 0.74 (0.45-1.20) 0.83 (0.49-1.42) 0.83 (0.48-1.45)
2014 0.51 (0.31-0.85) 0.55 (0.31-0.96) 0.49 (0.27-0.87)
Health Centre Characteristics
Location Urban 1.00 (reference) 1.00 (reference)
Regional 0.34 (0.16-0.72) 0.34 (0.16-0.73)
Remote 1.05 (0.56-1.98) 1.10 (0.59-2.06)
Duration of participation in ABCD CQI project Baseline 1.00 (reference) 1.00 (reference)
1-2 cycles 1.41 (1.16-1.70)b 1.47 (1.21-1.79)b
≥3 cycles 1.28 (0.99-1.67) 1.38 (1.05-1.80)
Provided adult health checka No 1.00 (reference) 1.00 (reference)
Yes 2.11 (1.83-2.44)b 2.24 (1.93-2.60)b
Provided Pap smear No 1.00 (reference) 1.00 (reference)
Yes 3.66 (3.24-4.14)b 4.39 (3.84-5.03)b
Patient Characteristics








Aboriginal Status Non-Aboriginal 1.00 (reference)
Aboriginal 1.33 (0.98-1.81)
Not recorded 0.96 (0.60-1.54)
Random effects (intercepts)
State (variance (SE)) 0.91 (0.63) 0.55 (0.40) 0.56 (0.40)
Health Centre (variance (SE)) 0.76 (0.14) 0.44 (0.087) 0.43 (0.085)
State & Health Centre (variance) 1.67 0.99 0.98
Patient (variance (SE)) 0.31 (0.16) 0.11 (0.057) 0.023 (0.013)
CQI continuous quality improvement, MOR Median Odds Ratio: odds of receiving above median service delivery if client was to change health centre or
jurisdiction, OR odds Ratio, PCV proportional change in variance: per cent variation explained in odds for better healthcare delivery by introduction of health
centre or client level factors, SRH Sexual and Reproductive Health
Due to multiple testing, the significance level is set at p < 0.005 (Bonferroni correction); ap < 0.005; b p < 0.0001
a(n = 6,645 with AHC recorded, introduced to audit tool in 2007)
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females than males (12.5 vs. 3.7%) and in 20–24 year
olds than 16–19 and 25–29 year age groups (9.0%, 8.7%
and 6.6% respectively) with the highest testing rates
among 20–24 year olds in the NT (21.9%) and females
in the NT (31.2%). More women are screened for STIs
in conjunction with a Pap smear and following discus-
sions about contraception. However, it is also likely to
reflect different health seeking behaviour [27] and their
higher access, compared to males, to more culturally ap-
propriate primary care given the largely female health
workforce in regional and remote Australia [28]. A focus
on opportunities to increase the number of males being
screened for STIs at primary health care is essential in
order to reduce the overall burden of infections. How-
ever, this necessitates greater understanding of the spe-
cific barriers to access of care for males, which have
included prioritising time for health care, lack of male
service providers and poorer access to health care [27].
Similarly, interventions to increase STI testing rates
among 15–19 year olds should be prioritised considering
the high incidence rates in this age group [29].
Among health centres that participated in the ABCD
CQI program, the NT and QLD health centres were the
highest performing, with the highest documented testing
rates for gonorrhoea, chlamydia and syphilis compared to
other jurisdictions. Known facilitators of best practice in
sexual health care include motivated and knowledgeable
health workers, creativity and innovation in delivery of
services including outreach services, offering STI screen-
ing as part of the AHC to reduce the stigma associated
with STI testing, use of nurses and other practice staff to
test clients, and provision of incentives [30, 31]. Barriers
to best practice include lack of knowledge and time,
workload load pressures, competing priorities and
gender-related, cultural, structural and organisational
factors [30, 31], with major concerns around privacy
and confidentiality particularly in smaller, more re-
mote Aboriginal communities [32, 33]. In both the
NT and QLD there was significant investment in CQI
infrastructure between 2009 and 2013, including the
establishment of regional CQI facilitator networks and
state-wide CQI planning and governance committees
[34, 35], which could explain the higher levels of
service delivery in these jurisdictions. It is noteworthy
that an ongoing syphilis outbreak in northern
Australia which began around January 2011, has re-
sulted in a renewed effort in monitoring, surveillance
and management of STIs in the region [36] and may
have impacted on the STI testing rates in these juris-
dictions. An additional explanatory factor for the
higher STI testing rates could be the concurrent STI-
specific CQI intervention, the STRIVE program, a
large randomised controlled trial which was con-
ducted among 68 remote Aboriginal communities in
the NT, QLD and services in northern WA between
2009 and 2014 [8]. Previous studies have shown that
STI-specific interventions have a positive impact on
STI testing rates [7], however, delineation of the im-
pact of these factors on delivery of sexual health ser-
vices in the NT and QLD will provide a better
understanding around what is needed for better deliv-
ery of care. Transferrable strategies that can be used
to improve service delivery in other regions and
within health centres with relatively lower documented
evidence of adherence to best practice guidelines are
needed. Improving delivery of care among services at the
lower end of the range of service delivery is critically
important to reducing inequities in care and raising the
standard of care at the population level.
Clients had three times the odds of receiving testing
for all three STIs and counselling if they had an AHC.
Health checks are primarily diagnostic and preventive,
and the Medicare Benefits Scheme (MBS) allows for the
Health Assessment for Aboriginal and Torres Strait
Islander People Item 715 (MBS 715) at least once every
nine months including a sexual health history, Pap
smears and testing for STIs [37]. Combining STI testing
with an AHC may be a way of normalising STI screening
and reducing stigma by removing emphasis from the
individual’s risk behaviour [30]. Our analysis shows that
only a quarter of clients had received an AHC within
24 months and an increase in AHCs would, by exten-
sion, lead to an increase in STI testing. However, yearly
AHCs may not be sufficient to control the high rates of
STI transmission, particularly in the 15–19 year old age
group that has very high documented incidence of chla-
mydia and gonorrhoea [29]. Adult health checks and
Pap smears could therefore be useful, in conjunction
with other measures, in improving STI testing in health
centres and among client groups with low testing rates
where STI-related stigma is an issue. As our study illus-
trated, the majority of the clients (92%) attended the
health centres for reasons other than a sexual health
assessment, so AHCs provide an opportunity for screen-
ing and reducing the burden of disease in otherwise ‘well
adults’. Considering that up to 80% of chlamydia infec-
tions are asymptomatic [38] as well as a significant pro-
portion of gonorrhoea infections [39], clients attending
the health centre for reasons other than a sexual health
consult could benefit from STI screening. There are a
range of patient-, interpersonal-, health service-, com-
munity- and policy-level barriers to follow-up care
following a health assessment, including high mobility,
costs, lack of transport, negative past experiences, poor
communication and lack of emphasis on follow up at
health system and policy levels [40]. Strategies at various
levels of the system to address barriers to follow-up
following STI testing are necessary to ensure continued
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benefits considering the substantial investment in health
assessments in Australia [40].
There are several limitations to this study that have to
be taken into consideration when interpreting the find-
ings. The auditing process collects a limited amount of
data so potential important factors may not be mea-
sured; health centre factors, contextual factors in the
wider community and structural and legislative factors
that may impact on delivery of care are not readily mea-
sured and quantified. Workload pressures at health
centre level were considered during development of the
audit tools; selecting indicators of relevance to Aborigi-
nal primary care centres reflects the service-orientation
of the ABCD projects. Lack of workforce data both in
terms of number and cadre of health workers at service
level and data on access to male and female service pro-
viders precludes analysis through our current dataset of
the impact of these factors on sexual health service de-
livery in this context. The fact that less than 50% of vari-
ation could be accounted for by the available health
centre and client factors indicates that there are other
factors underlying variation. Furthermore, the variation
in documented STI counselling and testing between re-
gions reflect a differing background STI prevalence, local
and regional guidelines and clinical practice. Variation in
testing may also be a reflection of access to laboratory
services, particularly in rural and remote regions. It is
expected that point-of-care testing will enhance early
diagnosis of STIs, particularly in remote areas where
there are significant delays in the management of STIs
[41]. Future studies, including qualitative assessments,
could elucidate the impact of these and other contextual
factors within health services with higher levels of
performance in order to understand the less tangible fac-
tors associated with higher quality of sexual health care.
Another limitation of this study is that auditing de-
pends on documentation of care in the client’s medical
record and audit data may not be a true reflection of
actual service delivery. This study could have underesti-
mated the number of STI tests and sexual health consul-
tations provided by the health centre, for instance in
circumstances where health centres facilitate community
outreach to increase clients’ access to STI testing and
counselling if this is not incorporated back into patient
information record systems. It is also not possible to
estimate the number of clients who could have accessed
these services outside their regular health centres, for
instance, highly mobile persons or those who have
access to other health services e.g. mainstream general
practices. The preventive audit is limited to 15–54 year
olds and excludes pregnant and postpartum women and
those with a diagnosis of a chronic disease; this may lead
to an underestimation of STI testing and counselling
conducted by health centres. Underlying assumptions in
the analysis were that all clients were sexually active and
that all females had an intact cervix, that is, not under-
gone a hysterectomy, thus possibly overestimating the
need for STI testing and counselling. Participation in
One21seventy and the ABCD National Research Part-
nership is voluntary; health centres were invited to
participate in the ABCD/One21seventy program [9] and
furthermore, asked to provide their data to the ABCD
NRP for research purposes [10], of which approximately
two-thirds did. Therefore data are not representative of
all primary health centres, regionally or nationally, and
largely reflect service activity in remote health centres in
the NT and QLD.
This study has elucidated several areas for improve-
ment and demonstrated that variation in STI-related
service delivery between health services is highly
dependent on health centre factors rather than client
factors, which highlights the critical need for structural
and organisational changes, rather than client-centred
interventions, to overcome the specific barriers to
provision of adequate care and improve sexual health
care delivery. Organisational-level interventions, includ-
ing creation of multidisciplinary clinical teams, revision
of professional roles, skills mix changes, and structural
changes [42], could help increase the number and cadre
of health professionals involved in sexual health care
and overcome specific barriers to provision of adequate
levels of care. The analysis has established a significant
association between AHCs and Pap smears with higher
levels of STI testing and counselling, suggesting that
AHCs and Pap smears act as catalysts for STI testing,
particularly in health centres with lower levels of docu-
mented care and in client groups with low STI testing
rates. Ultimately the primary health workforce and
health system will need to develop innovative ways to
increase STI testing to help reduce the burden of STIs
in the Aboriginal population as a means to reduce vari-
ation and enhance equity in quality of sexual health care.
Conclusions
This study has shown that a number of jurisdictions and
Aboriginal PHC centres are achieving high rates of STI
testing, providing an opportunity for better understand-
ing of what contributes to higher levels of performance
in sexual health care. There are a significant number of
health centres with relatively low documented evidence
of adherence to best practice and analysis shows that
variation is mainly attributed to health centre factors.
STI-related service delivery could be substantially im-
proved through focussed efforts to support delivery of
services in health centres, and to groups of clients, with
relatively lower documented evidence of adherence to
best practice guidelines. Documentation of AHCs and
Pap smear testing is associated with more testing for
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STIs and may contribute to earlier detection and treat-
ment of STIs, and STI testing should be included with
these interventions. Nevertheless, all PHC personnel
should be encouraged to consider STI screening for all
young men and women presenting to the health centre
for any reason, at every opportunity, without necessarily
waiting until the next AHC or Pap smear is due, in con-
junction with other approaches to increase STI testing in
high risk groups. Further analysis of local, regional and
jurisdictional factors that impact on sexual health service
delivery will assist health workers, PHC service managers
and policy makers develop targeted interventions to
improve service delivery. These approaches could help
enhance equity in quality of sexual health care, contribute
to the reduction in the high burden of STIs in the Aborigi-
nal population in Australia and contribute to an overall
improvement in quality of life for Aboriginal Australians.
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